Protocol measures. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Cry variables. by Sarah E. Maylott (14560785)

“…It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. Understanding which infants will develop NOWS soon after birth could reduce hospital stays for infants who do not develop NOWS and decrease burdens on hospitals and clinicians. …”

Significances of Tukey-HSD post-hoc tests for the group mean difference of the normalized maximal torques (lower left corner shaded in grey) in the knee extensors (KE), the hip abd... by Franziska Daun (6433328)

Related to Fig 1. by Amy E. Schade (15368259)

Axial plain chest CT images showing a ground-glass opacity (GGO) nodule in the left apex (74-year-old female weighing 49 kg). by Tsuneo Yamashiro (621385)

“…Nearly homogeneous density of the nodule was accurately depicted on images with AIDR3D at any of three tube currents (<b>A–C</b>). However, on images without AIDR3D (<b>D–F)</b>, artificial density heterogeneity due to image noise increased as the tube current decreased from 240 (<b>D</b>) to 60 mA (<b>F</b>).…”

Local sensitivity analysis of procoagulants, fibrin, F1.2 flux, and TAT flux. by Jason Chen (15937)

Jacobian determinant maps quantitatively illustrate mutant mouse differences. by Gregory A. Anderson (792214)

“…<i>Mlc2a</i> mutant mice display significant volume increases in the atrium of the developing heart compared to their wild-type and heterozygote counterparts (red shading sagittal sections, D and E, and a coronal section, F) at the 13–16 somite stage. …”

Fold change with steady state myocardial mRNA levels for components of the inflammasome. by Stephanie L. Samani (17896610)

SEC demonstrates that the monomeric population of fALS variants is decreased by <i>S</i>-XL6 treatment and that this is associated with reduced aggregation. by Md Amin Hossain (10170815)

Fig 1 - by Stephanie L. Samani (17896610)

Lumen diameter (77.9±5.6 vs 120.6±5.5 µm at 75 mmHg, <i>p</i><0.001), external diameter (110.4±6.4 vs 153.1±5.2 µm at 75 mmHg, <i>p</i><0.001) and media cross-sectional area (4860.4±464.7 vs 6972.4±272.1 µm² at 75 mmHg, <i>p</i><0.001) were increased in 16 wk-old db/db MRAs while wall:lumen ratio (21.3±1.2 vs 13.7±0.8 at 75 mmHg, <i>p</i><0.01) was decreased when compared to Db/db mice under physiological pressures of 50, 75 and 100 mmHg: a.... by Flavia M. Souza-Smith (346803)

S2 Table - by Penny A. Rudd (10298691)

Intraperitoneal hinokitiol injection does not decrease the number of live bacteria in BALF. by Toshihito Isono (8587668)

WSWE targets both cell wall and cell membrane of <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis by Elizabeth S. Mearns (731188)

“…We assessed the efficacy and safety of adjunctive antidiabetic agents in patients with inadequately controlled T2D on metformin alone.</p><p>Materials and Methods</p><p>A search of MEDLINE and CENTRAL, <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>, regulatory websites was performed. …”

Total Circulating Progenitor Cell (CPC) analysis through pregnancy and postpartum in control, type 1 and type 2 diabetic women. by Patricia D. A. Lima (707898)

Maternal information. by Patricia D. A. Lima (707898)

Early outgrowth colonies. by Patricia D. A. Lima (707898)

Gating strategy based on ISHAGE guidelines. by Patricia D. A. Lima (707898)

Total CD34+KDR+ cells across pregnancy and postpartum in control, type 1 and type 2 diabetic women. by Patricia D. A. Lima (707898)